研究人员开发了90%的精确测试来预测IBD病人的直肠癌风险。 Researchers develop a 90% accurate test to predict colorectal cancer risk in IBD patients.

伦敦的研究人员开发了一个新的测试,能够以90%的精确度预测炎症肠道疾病(IBD)患者患结肠癌的风险较高。 Researchers in London have developed a new test that can predict with 90% accuracy which patients with inflammatory bowel disease (IBD) are at a higher risk of developing colorectal cancer. 这一测试可以帮助确定需要更积极治疗的病人,有可能避免不必要的手术。 This test could help identify patients who need more aggressive treatment, potentially avoiding unnecessary surgeries. 经过进一步的临床试验后,可以通过联合王国国家保健服务机构提供测试。 After further clinical trials, the test may be offered through the UK's National Health Service.